Clinical Trial

A Feedback-enabled Magnetic Device for Temporary Management of Blepharoptosis

Recruiting
View on ClinicalTrials.gov →
Summary
To develop a feedback-enabled magnetic device for management of blepharoptosis and evaluate its efficacy and safety, including the gain of palpebral fissure height, visual field obstruction, blurred vision, foreign body sensation over the cornea, burning or hot sensation over facial skin, and erythema or pruritus over the eyelid, by performing a human trial on patients with blepharoptosis.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2019-01-18; most recent amendment 2025-05-11.
Status change: Active, Not Recruiting → Recruiting 2025-05-11
Status change: Recruiting → Active, Not Recruiting 2024-08-28
Status change: Suspended → Recruiting 2024-03-30
Status change: Recruiting → Suspended 2022-02-03
Trial Details
NCT Number NCT03812016
Lead Sponsor E-DA Hospital
Collaborators: National Yang Ming Chiao Tung University, The Industrial Technology Research Institute, Shin Kong Wu Ho-Su Memorial Hospital, National Science and Technology Council, Taiwan
Conditions Blepharoptosis, Device Usability
Enrollment 40 participants
Start Date 2023-04-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2026-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-05-14